FDA Approves Cobimetinib as Part of Drug Combination for Advanced Melanoma

| November 5, 2017 | 0 Comments
FDA Approves Cobimetinib as Part of Drug Combination for Advanced Melanoma

The FDA has approved the targeted drug cobimetinib, in combination with another targeted therapy, to treat patients with advanced melanoma whose tumors have specific genetic mutations.
See Original Article

Driving New Approaches to Cancer Prevention and Early Detection

Researchers are pioneering new approaches to preventing and screening for cancer, and the management of very early-stage disease.
See Original Article

President Obama’s Budget Request Affirms Commitment to Progress against Cancer

President Obama’s FY 2017 Budget Request includes $680 million to support Vice President Biden’s cancer research initiative.
See Original Article

Category: Recent News

About the Author ()

Leave a Reply